ROR2 and breast cancer: Furthermore, our results indicate that ROR2 overexpression activates PI3K, leading to AKT phosphorylation and activation, followed by up-regulation of PDK1 and cyclin D1, and down-regulation of p21, and resulting in the increased survival and proliferation of BC cells.